Diagnosis and Treatment of Hypercortisolism (Cushing's Syndrome)
After excluding exogenous glucocorticoid use, diagnose hypercortisolism using one of three initial tests—24-hour urinary free cortisol (at least two measurements), late-night salivary cortisol (two measurements), or 1 mg overnight dexamethasone suppression test—followed by a second confirmatory test if the first is abnormal, and refer to an endocrinologist for patients with concordant abnormal results. 1
Diagnostic Approach: A Stepwise Algorithm
Step 1: Exclude Exogenous Glucocorticoids
Before any testing, obtain a thorough drug history to rule out iatrogenic hypercortisolism from prescribed, inhaled, topical, or injected corticosteroids 1. This is the most common cause of Cushing's syndrome and must be eliminated first.
Step 2: Determine Who to Test
Do not screen broadly. Test only patients with:
- Multiple progressive features of Cushing's syndrome, particularly high-discriminatory features like proximal muscle weakness, wide purple striae, supraclavicular/temporal fat pads, or in children, weight gain with growth deceleration 1, 2
- Adrenal incidentalomas with clinical suspicion 1
- Unexplained weight gain combined with either decreased height velocity or declining height percentile in children 2
Avoid testing patients with isolated obesity, diabetes, or hypertension without additional progressive Cushingoid features 1.
Step 3: Initial Biochemical Testing
Choose one of these high-accuracy tests 1:
- 24-hour urinary free cortisol (UFC): Collect at least two separate 24-hour specimens. Abnormal if elevated above assay-specific normal range
- Late-night salivary cortisol: Obtain two measurements. Abnormal if >145 ng/dL (4 nmol/L)
- 1 mg overnight dexamethasone suppression test (DST): Give 1 mg dexamethasone at 11 PM-midnight, measure serum cortisol at 9 AM. Abnormal if cortisol >1.8 μg/dL (50 nmol/L)
- 48-hour low-dose DST: Give 0.5 mg dexamethasone every 6 hours for 48 hours, measure cortisol 6 hours after last dose. Abnormal if cortisol >1.8 μg/dL (50 nmol/L)
Special populations require test modifications 1:
- Pregnancy: Use UFC only; avoid dexamethasone testing
- Epilepsy on enzyme-inducing drugs: Avoid dexamethasone tests; use UFC, salivary, or serum cortisol instead
- Severe renal failure: Use 1 mg DST rather than UFC
- Suspected cyclic Cushing's: Use UFC or midnight salivary cortisol rather than DST
- Adrenal incidentaloma with mild features: Use 1 mg DST or late-night cortisol rather than UFC
Step 4: Interpret Initial Results and Proceed
If initial test is ABNORMAL:
- Refer to an endocrinologist 1
- Perform a second different test from the list above 1
- Consider dexamethasone-CRH test or midnight serum cortisol in specific situations 1
If two tests are concordantly ABNORMAL:
- Diagnosis of Cushing's syndrome is confirmed 1
- Proceed immediately to determine the etiology (see below)
If two tests are concordantly NORMAL:
- Stop further testing for Cushing's syndrome (except in rare suspected cyclic disease) 1
- If high pretest probability persists, reevaluate in 6 months if symptoms progress 1
If results are DISCORDANT:
- Perform additional testing, especially if pretest probability is high 1
- Evaluate for conditions causing false-positive results (pseudo-Cushing's states: depression, anxiety, alcoholism, poorly controlled diabetes, morbid obesity) 1
- Consider cyclic hypercortisolism and repeat testing during symptomatic periods 1
Step 5: Determine Etiology Once Hypercortisolism is Confirmed
Measure morning (8-9 AM) plasma ACTH 2, 3:
ACTH suppressed (<5 ng/L or <1.1 pmol/L):
- ACTH-independent (adrenal) Cushing's syndrome
- Obtain adrenal CT or MRI 4
- If unilateral adenoma: laparoscopic adrenalectomy 4
- If bilateral hyperplasia: consider adrenal vein sampling to assess lateralization 4
- If adrenal carcinoma suspected (>4-5 cm, irregular margins, heterogeneous): staging imaging and surgical resection 4
ACTH normal or elevated (>5 ng/L or >1.1 pmol/L):
- ACTH-dependent Cushing's syndrome (pituitary vs. ectopic)
- Obtain pituitary MRI 2, 3
- Perform CRH stimulation test: cortisol increase ≥20% suggests pituitary source 2
- If MRI shows no adenoma or results are equivocal: perform bilateral inferior petrosal sinus sampling (BIPSS) with CRH or desmopressin stimulation 2
Treatment Approach
Surgical Treatment (First-Line)
For Cushing's disease (pituitary):
- Transsphenoidal surgery by experienced neurosurgeon is first-line treatment 5, 6, 3
- Postoperative glucocorticoid replacement required until HPA axis recovers 4
For adrenal Cushing's:
- Laparoscopic adrenalectomy for unilateral adenoma 4
- Bilateral adrenalectomy for bilateral disease or failed medical management 4
- Postoperative lifelong glucocorticoid and mineralocorticoid replacement after bilateral adrenalectomy 4
For ectopic ACTH:
- Surgical resection of ectopic tumor if localized and resectable 4
- If unresectable: bilateral adrenalectomy or medical management 4
Medical Treatment Indications
Medical therapy is indicated in several scenarios 5, 6, 7:
- Severe hypercortisolism requiring rapid control before surgery
- Failed transsphenoidal surgery or surgical recurrence
- Waiting for radiation therapy effects (takes months to years)
- Non-surgical candidates or patient refusal of surgery
- Unresectable ectopic ACTH tumors
Medical Treatment Options
Adrenal steroidogenesis inhibitors (block cortisol production) 5, 7:
- Ketoconazole: 400-1200 mg/day; most commonly used, relatively tolerable 4, 5
- Osilodrostat: rapid onset (hours), highly effective 5, 7
- Metyrapone: rapid onset (hours), can be used in pregnancy with precautions 5, 7
- Mitotane: for adrenal carcinoma or severe disease 4
- Etomidate: intravenous, for hospitalized patients unable to take oral medications 5
Pituitary-directed agents 5, 7:
- Pasireotide: targets pituitary, potential tumor shrinkage, but high rate of hyperglycemia 5
- Cabergoline: for mild disease, slower onset, less effective but fewer side effects; avoid in bipolar disorder 5
Glucocorticoid receptor antagonist 5, 7:
- Mifepristone: blocks cortisol action, improves hyperglycemia and weight; challenging to monitor (cortisol levels unreliable), risk of hypokalemia, requires experienced clinician 5
Treatment Strategy Selection
For severe hypercortisolism 5:
- Use steroidogenesis inhibitors (osilodrostat, metyrapone, or ketoconazole) for rapid cortisol normalization
- Consider combination therapy if monotherapy insufficient
- If refractory to medical therapy: proceed to bilateral adrenalectomy
For mild-to-moderate disease 5:
- Ketoconazole, osilodrostat, or metyrapone as first-line
- Consider cabergoline or pasireotide if residual tumor present and tumor shrinkage desired
- Avoid pasireotide in patients with diabetes or high diabetes risk
- Titration approach: gradually increase drug dose to normalize cortisol (most common)
- Block-and-replace approach: use higher doses to fully suppress cortisol, then add glucocorticoid replacement
- Monitor with serial UFC and late-night salivary cortisol measurements
- Watch for adrenal insufficiency, adjust doses accordingly
Critical Pitfalls to Avoid
False-positive screening: Pseudo-Cushing's states (depression, alcoholism, poorly controlled diabetes, obesity) can mimic biochemical hypercortisolism 1. The 48-hour low-dose DST has better specificity in these populations 1.
Drug interactions with dexamethasone: Antiepileptic drugs (phenytoin, carbamazepine, phenobarbital) accelerate dexamethasone clearance, causing false-positive DST results 1. Use alternative tests in these patients.
Assay variability: Cortisol assays differ significantly; interpret results using assay-specific reference ranges 1. Antibody-based assays may cross-react with synthetic glucocorticoids and metabolites.
Cyclic Cushing's: Patients may have normal tests during quiescent phases 1. Repeat testing during symptomatic periods or use serial UFC/salivary cortisol measurements.
Pediatric considerations: In children <40 kg, adjust dexamethasone dose to 30 μg/kg/day for 48-hour DST 1. Growth failure combined with weight gain is highly specific for Cushing's in prepubertal children 2.
Mifepristone monitoring: Cannot use cortisol levels to monitor treatment or detect adrenal insufficiency 5. Reserve for experienced clinicians only.